跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-FULVESTRANT INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-FULVESTRANT INJECTION
Authorized
STANDARD
TEVA-FULVESTRANT INJECTION
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b5bc9a78aaffd85f
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
b5bc9a78aaffd85f
Drug Approval Canada Name
TEVA-FULVESTRANT INJECTION
Product Name
TEVA-FULVESTRANT INJECTION
Status
Marketed
Status Date
2019-01-15
Original Market Date
2019-01-15
Din
02460130
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intramuscular
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L02BA03 FULVESTRANT
Atc Name
l 02 ba 03
Aig Number
0149744001
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
FULVESTRANT
50 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b5bc9a78aaffd85f
Type
Standard
Back to Health Canada Approvals